logo
← Back to RNS Announcements

DIRECTORATE CHANGE

In accordance with Listing Rule 9.6.11R the Board of International Biotechnology Trust plc announces that Mr Alan Clifton will be retiring as the Chairman of the Board and as a Director of the Company at the conclusion of the Annual General Meeting to be held on Tuesday, 12 December 2017. Further, Mr John Aston, an existing Director of the Company, will succeed him as Chairman of the Board immediately following his retirement.

Published on 1st November 2017

Science background with molecule or atom Abstract structure for Science or medical background
Science background with molecule or atom Abstract structure for Science or medical background

RNS Number : 3019V

Intl. Biotechnology Trust PLC

01 November 2017

INTERNATIONAL BIOTECHNOLOGY TRUST plc (the Company)

Change of Chairman

In accordance with Listing Rule 9.6.11R the Board of International Biotechnology Trust plc announces that Mr Alan Clifton will be retiring as the Chairman of the Board and as a Director of the Company at the conclusion of the Annual General Meeting to be held on Tuesday, 12 December 2017. Further, Mr John Aston, an existing Director of the Company, will succeed him as Chairman of the Board immediately following his retirement.

Susan Gledhill

For and on behalf of

BNP Paribas Secretarial Services Limited

Company Secretary

Tel: 020 7410 5971

Disclaimer

The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

The material on this website is intended to be viewed only by persons resident in the EEA.

The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).


I do not accept →